DOCSLIB.ORG

Study of Vesicular Glycolysis in Health and Huntington's Disease

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Study of Vesicular Glycolysis in Health and Huntington's Disease Study of vesicular glycolysis in health and Huntington’s Disease Maximilian Mc Cluskey To cite this version: Maximilian Mc Cluskey. Study of vesicular glycolysis in health and Huntington’s Disease. Neurons and Cognition [q-bio.NC]. Université Grenoble Alpes [2020-..], 2021. English. NNT : 2021GRALV006. tel-03251320 HAL Id: tel-03251320 https://tel.archives-ouvertes.fr/tel-03251320 Submitted on 7 Jun 2021 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. THÈSE Pour obtenir le grade de DOCTEUR DE L’UNIVERSITE GRENOBLE ALPES Spécialité : Neurosciences, Neurobiologie Arrêté ministériel : 25 mai 2016 Présentée par Maximilian Mc CLUSKEY Thèse dirigée par Frédéric SAUDOU et co-encadrée par Anne-Sophie NICOT préparée au sein du Grenoble Institut des Neurosciences dans l'École Doctorale de Chimie et Sciences du Vivant Study of vesicular glycolysis in health and Huntington’s disease Thèse soutenue publiquement le 04/02/2021, devant le jury composé de : Mr, Frédéric, DARIOS Chargé de recherche INSERM, Institut du Cerveau, rapporteur Mme, Carine, POURIÉ Professeure des universités, Université de Lorraine, rapporteuse Mr, Hervé, DUBOUCHAUD Professeur des Universités, Université Grenoble Alpes, examinateur Mme, Isabelle, ARNAL Directrice de recherche CNRS, Grenoble Institut des Neurosciences, présidente Mr, Frédéric, SAUDOU Professeur des universités - Practicien hospitalier, Grenoble Institut des Neurosciences, directeur de thèse, Invité Mme, Anne-Sophie, NICOT Maitre de conférence des universités, Grenoble Institut des Neurosciences, co-encadrante, Invité 1 2 ACKNOWLEDGEMENTS I would first like to thank the members of my jury, Dr. Frédéric Darios, Pr. Carine Bossenmeyer-Pourié, Pr. Hervé Dubouchaud and Dr. Isabelle Arnal. Your time spent reading, commenting and discussing this work has been highly appreciated. I would also like to thank my PhD supervisor, Pr. Frédéric Saudou, and co-supervisor, Dr. Anne-Sophie Nicot, for their guidance and trust in my abilities, that has been instrumental in rendering this work possible. I would finally like to thank all members of the team that contributed in some way to this work and made my time at the Grenoble Institute of Neuroscience that much more meaningful. 3 Contents I. ABSTRACT ....................................................................................................................... 8 II. RÉSUMÉ .......................................................................................................................... 10 III. ABBREVIATIONS .......................................................................................................... 12 IV. LIST OF FIGURES .......................................................................................................... 15 V. INTRODUCTION ............................................................................................................ 16 A. Chapter 1: Huntington’s disease .................................................................................. 16 1. General description of Huntington’s disease ........................................................... 16 a) Discovery & history of Huntington’s disease .................................................... 16 b) Prevalence, statistics & heritability of Huntington’s disease in humans ........... 16 c) Symptoms .......................................................................................................... 19 (1) Motor .............................................................................................................. 19 (2) Cognitive ........................................................................................................ 19 (3) Psychiatric ...................................................................................................... 20 (4) Other symptoms ............................................................................................. 21 2. Animal models of Huntington’s disease .................................................................. 22 a) Mouse models .................................................................................................... 22 b) Other models ...................................................................................................... 23 3. Neurodegeneration and cellular dysfunction ........................................................... 24 a) Neurodegeneration ............................................................................................. 24 b) Cellular features and dysfunctions ..................................................................... 26 (1) Inclusion bodies.............................................................................................. 26 (2) Cortico-striatal imbalance .............................................................................. 26 (3) Axonal transport ............................................................................................. 28 (4) Energy metabolism ......................................................................................... 29 (5) Synaptic transmission ..................................................................................... 30 (6) Glia ................................................................................................................. 31 (7) Other dysfunctions ......................................................................................... 33 4. Treating Huntington’s disease ................................................................................. 34 a) Symptomatic treatment ...................................................................................... 34 b) Genetic therapy .................................................................................................. 34 c) Non-genetic therapy ........................................................................................... 36 B. Chapter 2: Huntingtin protein and function ................................................................. 38 1. From huntingtin gene to huntingtin protein ............................................................. 38 a) The huntingtin gene and transcription ............................................................... 38 b) Huntingtin localization....................................................................................... 38 4 c) HTT protein structure ........................................................................................ 39 d) HTT interactors .................................................................................................. 41 e) HTT proteolysis ................................................................................................. 41 2. Huntingtin post-translational modifications ............................................................ 42 a) Acetylation ......................................................................................................... 42 b) SUMOylation and ubiquitination ....................................................................... 43 c) Phosphorylation ................................................................................................. 43 d) Palmitoylation and methylation ......................................................................... 44 3. Huntingtin functions ................................................................................................ 45 a) Axonal transport................................................................................................. 45 b) Endocytosis ........................................................................................................ 46 c) Ciliogenesis ........................................................................................................ 47 d) Cell division ....................................................................................................... 47 e) Protein degradation ............................................................................................ 47 f) Transcription ...................................................................................................... 48 C. Chapter 3: Axonal transport ......................................................................................... 49 1. Basics of axonal transport ........................................................................................ 49 a) General description of axonal transport ............................................................. 49 b) Molecular motors ............................................................................................... 50 c) Axonal cargo dynamics and motors ................................................................... 53 (1) Fast axonal transport ...................................................................................... 53 (2) Slow axonal transport ..................................................................................... 56 2. Regulating and powering axonal transport .............................................................. 57 a) Regulation mechanisms of axonal
Load more

Recommended publications
  • Protein Identities in Evs Isolated from U87-MG GBM Cells As Determined by NG LC-MS/MS
    Protein identities in EVs isolated from U87-MG GBM cells as determined by NG LC-MS/MS. No. Accession Description Σ Coverage Σ# Proteins Σ# Unique Peptides Σ# Peptides Σ# PSMs # AAs MW [kDa] calc. pI 1 A8MS94 Putative golgin subfamily A member 2-like protein 5 OS=Homo sapiens PE=5 SV=2 - [GG2L5_HUMAN] 100 1 1 7 88 110 12,03704523 5,681152344 2 P60660 Myosin light polypeptide 6 OS=Homo sapiens GN=MYL6 PE=1 SV=2 - [MYL6_HUMAN] 100 3 5 17 173 151 16,91913397 4,652832031 3 Q6ZYL4 General transcription factor IIH subunit 5 OS=Homo sapiens GN=GTF2H5 PE=1 SV=1 - [TF2H5_HUMAN] 98,59 1 1 4 13 71 8,048185945 4,652832031 4 P60709 Actin, cytoplasmic 1 OS=Homo sapiens GN=ACTB PE=1 SV=1 - [ACTB_HUMAN] 97,6 5 5 35 917 375 41,70973209 5,478027344 5 P13489 Ribonuclease inhibitor OS=Homo sapiens GN=RNH1 PE=1 SV=2 - [RINI_HUMAN] 96,75 1 12 37 173 461 49,94108966 4,817871094 6 P09382 Galectin-1 OS=Homo sapiens GN=LGALS1 PE=1 SV=2 - [LEG1_HUMAN] 96,3 1 7 14 283 135 14,70620005 5,503417969 7 P60174 Triosephosphate isomerase OS=Homo sapiens GN=TPI1 PE=1 SV=3 - [TPIS_HUMAN] 95,1 3 16 25 375 286 30,77169764 5,922363281 8 P04406 Glyceraldehyde-3-phosphate dehydrogenase OS=Homo sapiens GN=GAPDH PE=1 SV=3 - [G3P_HUMAN] 94,63 2 13 31 509 335 36,03039959 8,455566406 9 Q15185 Prostaglandin E synthase 3 OS=Homo sapiens GN=PTGES3 PE=1 SV=1 - [TEBP_HUMAN] 93,13 1 5 12 74 160 18,68541938 4,538574219 10 P09417 Dihydropteridine reductase OS=Homo sapiens GN=QDPR PE=1 SV=2 - [DHPR_HUMAN] 93,03 1 1 17 69 244 25,77302971 7,371582031 11 P01911 HLA class II histocompatibility antigen,
    [Show full text]
  • Hungry for Your Alanine: When Liver Depends on Muscle Proteolysis
    The Journal of Clinical Investigation COMMENTARY Hungry for your alanine: when liver depends on muscle proteolysis Theresia Sarabhai1,2 and Michael Roden1,2,3 1Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany. 2German Center for Diabetes Research, München-Neuherberg, Germany. 3Division of Endocrinology and Diabetology, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany. β-oxidation and the acetyl-CoA pool, which Fasting requires complex endocrine and metabolic interorgan crosstalk, allosterically activates pyruvate carboxylase flux (V ), and which, together with glycerol which involves shifting from glucose to fatty acid oxidation, derived from PC adipose tissue lipolysis, in order to preserve glucose for the brain. The as substrate, maintains the rates of hepatic gluconeogenesis and endogenous glucose glucose-alanine (Cahill) cycle is critical for regenerating glucose. In this issue production (V ) (8). of JCI, Petersen et al. report on their use of an innovative stable isotope EGP tracer method to show that skeletal muscle–derived alanine becomes rate Liver–skeletal muscle controlling for hepatic mitochondrial oxidation and, in turn, for glucose metabolic crosstalk production during prolonged fasting. These results provide new insight Other metabolic pathways are also known into skeletal muscle–liver metabolic crosstalk during the fed-to-fasting to connect skeletal muscle and liver. The transition in humans. Cori
    [Show full text]
  • Thèse De Doctorat
    THÈSE DE DOCTORAT Rôle des microARNs et de leur machinerie dans les hépatocytes et les cellules béta pancréatiques Role of microRNAs and their machinery in hepatocytes and pancreatic beta cells Gaia FABRIS IRCAN CNRS UMR 7284 – INSERM U1081 Présentée en vue de l’obtention Devant le jury, composé de : du grade de docteur en Sciences Francesco Beguinot, Professeur d’Université Côte d’Azur d’Endocrinologie, Università di Napoli Mention : interactions moléculaires et Federico II cellulaires Giulia Chinetti, Professeure de Biochimie, Dirigée par : Giulia Chinetti UCA Nice Co-encadrée par : Patricia Lebrun Magalie Ravier, CRCN, Inserm, IGF Soutenue le : 7 Juin 2019 Montpellier Emmanuel Van Obberghen, Professeur de Biochimie, UCA Nice Rôle des microARNs et de leur machinerie dans les hépatocytes et les cellules béta pancréatiques Jury : Président de jury Emmanuel Van Obberghen, Professeur de Biochimie, UCA Nice Rapporteurs Faeso Beguiot, Pofesseu d’Endocrinologie, Département de Médecine translationnelle Université de Naples Federico II, Italie Magalie Ravier, CRCN, Inserm, Institut de Génomique Fonctionnelle Montpellier, France Résumé Das le foie oal de l’adulte les hpatotes sot das u tat de uiesee, sauf los d’ue situatio d’agessio phsiue ou toique. Dans ces cas-là, afin de pouvoir aitei leu ôle das l’hoostasie de l’ogaise les hpatotes edoags ou sauvegardés vont proliférer. Un des facteurs limitants pour la prolifération est la psee d’aides ais, ui sot essaies pour la synthèse des protéines au cours de la polifatio et diisio ellulaie, et pou l’atiatio de la oie TOR, ui joue un rôle clef dans la régulation de la prolifération cellulaire.
    [Show full text]
  • Hepatocyte Specific Expression of an Oncogenic Variant of Β-Catenin Results in Lethal Metabolic Dysfunction in Mice
    www.impactjournals.com/oncotarget/ Oncotarget, 2018, Vol. 9, (No. 13), pp: 11243-11257 Research Paper Hepatocyte specific expression of an oncogenic variant of β-catenin results in lethal metabolic dysfunction in mice Ursula J. Lemberger1,2, Claudia D. Fuchs2, Christian Schöfer3, Andrea Bileck4, Christopher Gerner4, Tatjana Stojakovic5, Makoto M. Taketo6, Michael Trauner2, Gerda Egger1,7 and Christoph H. Österreicher8 1Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria 2Hans Popper Laboratory for Molecular Hepatology, Department of Internal Medicine, Medical University of Vienna, Vienna, Austria 3Department of Cell and Developmental Biology, Medical University of Vienna, Vienna, Austria 4Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria 5Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria 6Division of Experimental Therapeutics, Graduate School of Medicine, Kyoto University, Kyoto, Japan 7Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria 8Institute of Pharmacology, Medical University Vienna, Vienna, Austria Correspondence to: Ursula J. Lemberger, email: [email protected], [email protected] Keywords: Wnt signaling pathway; liver cancer; lipid metabolism; glucose metabolism; mitochondrial disorder Received: August 31, 2017 Accepted: January 25, 2018 Published: January 30, 2018 Copyright: Lemberger et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT Background: Wnt/β-catenin signaling plays a crucial role in embryogenesis, tissue homeostasis, metabolism and malignant transformation of different organs including the liver. Continuous β-catenin signaling due to somatic mutations in exon 3 of the Ctnnb1 gene is associated with different liver diseases including cancer and cholestasis.
    [Show full text]
  • The Impact of Acute Thermal Stress on the Metabolome of the Black Rockfish (Sebastes Schlegelii)
    RESEARCH ARTICLE The impact of acute thermal stress on the metabolome of the black rockfish (Sebastes schlegelii) 1☯³ 1☯³ 1 1 1 1 Min SongID , Ji Zhao , Hai-Shen Wen *, Yun Li *, Ji-Fang Li , Lan-Min Li , Ya- Xiong Tao2 1 Key Laboratory of Mariculture (Ocean University of China), Ministry of Education, Ocean University of China, Qingdao, P. R. China, 2 Department of Anatomy, Physiology and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, AL, United States of America a1111111111 ☯ These authors contributed equally to this work. a1111111111 ³ These authors are co-first authors on this work. a1111111111 * [email protected] (HSW); [email protected] (YL) a1111111111 a1111111111 Abstract Acute change in water temperature causes heavy economic losses in the aquaculture industry. The present study investigated the metabolic and molecular effects of acute ther- OPEN ACCESS mal stress on black rockfish (Sebastes schlegelii). Gas chromatography time-of-flight mass Citation: Song M, Zhao J, Wen H-S, Li Y, Li J-F, Li spectrometry (GC-TOF-MS)-based metabolomics was used to investigate the global meta- L-M, et al. (2019) The impact of acute thermal stress on the metabolome of the black rockfish bolic response of black rockfish at a high water temperature (27ÊC), low water temperature (Sebastes schlegelii). PLoS ONE 14(5): e0217133. (5ÊC) and normal water temperature (16ÊC). Metabolites involved in energy metabolism and https://doi.org/10.1371/journal.pone.0217133 basic amino acids were significantly increased upon acute exposure to 27ÊC (P < 0.05), and Editor: Jose L. Soengas, Universidade de Vigo, no change in metabolite levels occurred in the low water temperature group.
    [Show full text]
  • The Proteomic Landscape of Resting and Activated CD4+ T Cells Reveal Insights Into Cell Differentiation and Function
    International Journal of Molecular Sciences Article The Proteomic Landscape of Resting and Activated CD4+ T Cells Reveal Insights into Cell Differentiation and Function Yashwanth Subbannayya 1 , Markus Haug 1, Sneha M. Pinto 1, Varshasnata Mohanty 2, Hany Zakaria Meås 1, Trude Helen Flo 1, T.S. Keshava Prasad 2 and Richard K. Kandasamy 1,* 1 Centre of Molecular Inflammation Research (CEMIR), Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, 7491 Trondheim, Norway; [email protected] (Y.S.); [email protected] (M.H.); [email protected] (S.M.P.); [email protected] (H.Z.M.); trude.fl[email protected] (T.H.F.) 2 Center for Systems Biology and Molecular Medicine, Yenepoya (Deemed to be University), Mangalore 575018, India; [email protected] (V.M.); [email protected] (T.S.K.P.) * Correspondence: [email protected] Abstract: CD4+ T cells (T helper cells) are cytokine-producing adaptive immune cells that activate or regulate the responses of various immune cells. The activation and functional status of CD4+ T cells is important for adequate responses to pathogen infections but has also been associated with auto-immune disorders and survival in several cancers. In the current study, we carried out a label-free high-resolution FTMS-based proteomic profiling of resting and T cell receptor-activated (72 h) primary human CD4+ T cells from peripheral blood of healthy donors as well as SUP-T1 cells. We identified 5237 proteins, of which significant alterations in the levels of 1119 proteins were observed between resting and activated CD4+ T cells.
    [Show full text]
  • Downloaded from Ftp://Ftp.Uniprot.Org/ on July 3, 2019) Using Maxquant (V1.6.10.43) Search Algorithm
    bioRxiv preprint doi: https://doi.org/10.1101/2020.11.17.385096; this version posted November 17, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. The proteomic landscape of resting and activated CD4+ T cells reveal insights into cell differentiation and function Yashwanth Subbannayya1, Markus Haug1, Sneha M. Pinto1, Varshasnata Mohanty2, Hany Zakaria Meås1, Trude Helen Flo1, T.S. Keshava Prasad2 and Richard K. Kandasamy1,* 1Centre of Molecular Inflammation Research (CEMIR), and Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, N-7491 Trondheim, Norway 2Center for Systems Biology and Molecular Medicine, Yenepoya (Deemed to be University), Mangalore, India *Correspondence to: Professor Richard Kumaran Kandasamy Norwegian University of Science and Technology (NTNU) Centre of Molecular Inflammation Research (CEMIR) PO Box 8905 MTFS Trondheim 7491 Norway E-mail: [email protected] (Kandasamy R K) Tel.: +47-7282-4511 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.11.17.385096; this version posted November 17, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. Abstract CD4+ T cells (T helper cells) are cytokine-producing adaptive immune cells that activate or regulate the responses of various immune cells.
    [Show full text]
  • Part 2 Biochemistry of Hormones. Metabolism of Carbohydrates and Lipids Частина 2 Біохімія Гормонів. О
    МІНІСТЕРСТВО ОХОРОНИ ЗДОРОВ'Я УКРАЇНИ Харківський національний медичний університет PART 2 BIOCHEMISTRY OF HORMONES. METABOLISM OF CARBOHYDRATES AND LIPIDS Self-Study Guide for Students of General Medicine Faculty in Biochemistry ЧАСТИНА 2 БІОХІМІЯ ГОРМОНІВ. ОБМІН ВУГЛЕВОДІВ ТА ЛІПІДІВ Методичні вказівки для підготовки до практичних занять з біологічної хімії (для студентів медичних факультетів) Затверджено вченою Радою ХНМУ Протокол № 12 від 20.10.2016 р. Харків ХНМУ 2016 Self-study guide for students of general medicine faculty in biochemistry. Part 2: Biochemistry of hormones. Metabolism of carbohydrates and lipids / Comp.: O. Nakonechna, S. Stetsenko, L. Popova, A. Tkachenko. et al. – Kharkiv: KhNMU, 2016. – 84 p. Covpilers: Nakonechna O. Stetsenko S. Popova L. Tkachenko A. Методичні вказівки для підготовки до практичних занять з біологічної хімії (для студентів медичних факультетів). Частина 2. Біохімія гормонів. Обмін вуглеводів і ліпідів / Упоряд. О.А. Наконечна, С.О. Стеценко, Л.Д. Попова, А.С. Ткаченко. – Харків: ХНМУ, 2016. – 84 с. Упорядники: О.А. Наконечна С.О. Стеценко Л.Д. Попова А.С. Ткаченко - 2 - SOURCES For preparing to practical classes in «Biological Chemistry» Basic Sources 1. Біологічна і біоорганічна хімія: у 2 кн.: підручник. Кн. 2 Біологічна хімія / Ю.І. Губський, І.В. Ніженковська, М.М. Корда, В.І. Жуков та ін.; за ред. Ю.І. Губського, І.В. Ніженковської. – К.: ВСВ «Медицина», 2016. – 544 с. 2. Губський Ю.І. Біологічна хімія. Підручник / Губський Ю.І. – Київ-Вінниця: Нова книга, 2007. – 656 с. 3. Губський Ю.І. Біологічна хімія / Губський Ю.І. – Київ-Тернопіль: Укрмедкнига, 2000. – 508 с. 4. Гонський Я.І. Біохімія людини. Підручник / Гонський Я.І., Максимчук Т.П., Калинський М.І.
    [Show full text]
  • Pregnant and Early Lactation Dairy Cows: Implications to Liver-Muscle Crosstalk
    RESEARCH ARTICLE Metabolic Response to Heat Stress in Late- Pregnant and Early Lactation Dairy Cows: Implications to Liver-Muscle Crosstalk Franziska Koch1☯, Ole Lamp1,2☯, Mehdi Eslamizad1,3, Joachim Weitzel4, Björn Kuhla1* 1 Institute of Nutritional Physiology “Oskar Kellner”, Leibnitz Institute for Farm Animal Biology (FBN), Dummerstorf, Germany, 2 Schleswig Holstein Chamber of Agriculture, Department of Animal production, Futterkamp, Blekendorf, Germany, 3 Department of Animal Science, Campus of Agriculture and Natural Resources, University of Tehran, Tehran, Iran, 4 Institute of Reproductive Biology, Leibnitz Institute for Farm Animal Biology (FBN), Dummerstorf, Germany a11111 ☯ These authors contributed equally to this work. * [email protected] Abstract OPEN ACCESS Climate changes lead to rising temperatures during summer periods and dramatic eco- nomic losses in dairy production. Modern high-yielding dairy cows experience severe meta- Citation: Koch F, Lamp O, Eslamizad M, Weitzel J, bolic stress during the transition period between late gestation and early lactation to meet Kuhla B (2016) Metabolic Response to Heat Stress in Late-Pregnant and Early Lactation Dairy Cows: the high energy and nutrient requirements of the fetus or the mammary gland, and addi- Implications to Liver-Muscle Crosstalk. PLoS ONE 11 tional thermal stress during this time has adverse implications on metabolism and welfare. (8): e0160912. doi:10.1371/journal.pone.0160912 The mechanisms enabling metabolic adaptation to heat apart from the decline in feed intake Editor: Andrew C. Gill, University of Edinburgh, and milk yield are not fully elucidated yet. To distinguish between feed intake and heat UNITED KINGDOM stress related effects, German Holstein dairy cows were first kept at thermoneutral condi- Received: April 5, 2016 tions at 15°C followed by exposure to heat-stressed (HS) at 28°C or pair-feeding (PF) at Accepted: July 27, 2016 15°C for 6 days; in late-pregnancy and again in early lactation.
    [Show full text]
  • Carla Freire Celedonio Fernandes Molecular Characterization And
    www.doktorverlag.de [email protected] Tel: 0641-5599888 Fax: -5599890 Tel: D-35396 GIESSEN ST AU FEN BER G R I N G 1 5 VVB LAUFERSWEILERVERLAG VVB LAUFERSWEILER VERLAG VVB LAUFERSWEILER édition scientifique 9783835 952300 ISBN 3-8359-5230-7 ISBN VVB CARLA FREIRE CELEDONIO FERNANDE S SLC10A4 AND SLC10A5 Carla FreireCeledonioFernandes Expression ofTwoNewMembers of theSLC10TransporterFamily: Molecular Characterizationand VVB LAUFERSWEILER VERLAG VVB LAUFERSWEILER SLC10A4 andSLC10A5 Doktorgrades der Naturwissenchaften dem Fachbereich Pharmazie der Dissertation zur Erlangung des édition scientifique édition Philipps-Universität Marburg (Dr. rer. Nat.) Das Werk ist in allen seinen Teilen urheberrechtlich geschützt. Jede Verwertung ist ohne schriftliche Zustimmung des Autors oder des Verlages unzulässig. Das gilt insbesondere für Vervielfältigungen, Übersetzungen, Mikroverfilmungen und die Einspeicherung in und Verarbeitung durch elektronische Systeme. 1. Auflage 2007 All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior written permission of the Author or the Publishers. 1st Edition 2007 © 2007 by VVB LAUFERSWEILER VERLAG, Giessen Printed in Germany VVB LAUFERSWEILER VERLAG édition scientifique STAUFENBERGRING 15, D-35396 GIESSEN Tel: 0641-5599888 Fax: 0641-5599890 email: [email protected] www.doktorverlag.de Aus dem Institut für Pharmakologie und Toxikologie der Philipps-Universität Marburg Betreuer: Prof. Dr. Dr. Joseph Krieglstein und dem Institut für Pharmakologie und Toxikologie der Justus-Liebig-Universität Gießen Betreuer: Prof. Dr. Ernst Petzinger Molecular Characterization and Expression of Two New Members of the SLC10 Transporter Family: SLC10A4 and SLC10A5 Dissertation zur Erlangung des Doktorgrades der Naturwissenchaften (Dr.
    [Show full text]
  • SUPPORT GUIDE Contents ORGANIC ACIDS OXIDATIVE STRESS MARKERS AMINO ACIDS FATTY ACIDS TOXIC and NUTRIENT ELEMENTS
    & SUPPORT GUIDE Contents ORGANIC ACIDS OXIDATIVE STRESS MARKERS AMINO ACIDS FATTY ACIDS TOXIC AND NUTRIENT ELEMENTS Organic Acids NUTRITIONAL Oxidative Stress NUTRITIONAL Amino Acids Plasma NUTRITIONAL Essential & Metabolic Fatty Acids NUTRITIONAL Elements NUTRITIONAL 2. NutrEval Profile The NutrEval profile is the most comprehensive functional and nutritional assessment available. It is designed to help practitioners identify root causes of dysfunction and treat clinical imbalances that are inhibiting optimal health. This advanced diagnostic tool provides a systems-based approach for clinicians to help their patients overcome chronic conditions and live a healthier life. The NutrEval assesses a broad array of macronutrients and micronutrients, as well as markers that give insight into digestive function, toxic exposure, mitochondrial function, and oxidative stress. It accomplishes this by evaluating organic acids, amino acids, fatty acids, oxidative stress markers, and nutrient & toxic elements. Subpanels of the NutrEval are also available as stand-alone options for a more focused assessment. The NutrEval offers a user-friendly report with clinically actionable results including: • Nutrient recommendations for key vitamins, minerals, amino acids, fatty acids, and digestive support based on a functional evaluation of important biomarkers • Functional pillars with a built-in scoring system to guide therapy around needs for methylation support, toxic exposures, mitochondrial dysfunction, fatty acid imbalances, and oxidative stress • Interpretation-At-A-Glance pages providing educational information on nutrient function, causes and complications of deficiencies, and dietary sources • Dynamic biochemical pathway charts to provide a clear understanding of how specific biomarkers play a role in biochemistry There are various methods of assessing nutrient status, including intracellular, extracellular, direct, and functional measurements.
    [Show full text]
  • GLUCONEOGENESIS Defined As Biosynthesis of Glucose from Non
    GLUCONEOGENESIS Defined as biosynthesis of glucose from non-carbohydrate precursors. Gluconeogenesis is the biosynthesis of new glucose from non-carbohydrate substances such as pyruvate lactate Glycosylated amino acids Propionic acid derived from odd chain fatty acids Glycerol part of fat. It takes place mainly in liver and to a lesser extent in renal cortex. The cycle is partly in mitochondrial and partly in cytoplasmic Sources for Gluconeogenesis Alanine: It is produced from other amino acids derived from tissue protein break down Glycerol: lipid mobilization from adipose tissue & lipolysis Lactate: anaerobic glycolysis in tissues such as working muscle or RBCs Propionate: from odd chain length fatty acids The one which is helping when body really needs glucose is Glucogenic Aminoacids especially Alanine Cori’s cycle The cycle involving synthesis of glucose in liver from the skeletal muscle lactate and the reuse of glucose by the muscle for energy purpose is known as cori cycle Transferring lactate from tissue to liver and synthesis of glucose is known as cori’s cycle. Effects It rescues lactate for further use (gluconeogenesis) It counteracts lactic acidosis. It is of less importance in starvation but important in more normal situations especially in certain cells such as matured RBC, medulla, retina which are lacking mitochondria and virtually anaerobic. It does not consume any energy Pyruvate to Phosphoenolpyruvate Endergonic & requires free energy input. This is accomplished by first converting the pyruvate to oxaloacetate, a “high-energy” intermediate. CO2 is added to pyruvate by pyruvate carboxylase enzyme. CO2 that was added to pyruvate to form OAA is released in the reaction catalyzed by phosphoenolpyruvate carboxykinase (PEPCK) to form PEP, Exergonic decarboxylation OAA provides the free energy necessary for PEP synthesis.
    [Show full text]